These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
225 related articles for article (PubMed ID: 28653223)
1. Multi-targeted therapy of everolimus in Kaposi's sarcoma associated herpes virus infected primary effusion lymphoma. Mohanty S; Kumar A; Das P; Sahu SK; Choudhuri T Apoptosis; 2017 Sep; 22(9):1098-1115. PubMed ID: 28653223 [TBL] [Abstract][Full Text] [Related]
2. Repurposing Cytarabine for Treating Primary Effusion Lymphoma by Targeting Kaposi's Sarcoma-Associated Herpesvirus Latent and Lytic Replications. Gruffaz M; Zhou S; Vasan K; Rushing T; Michael QL; Lu C; Jung JU; Gao SJ mBio; 2018 May; 9(3):. PubMed ID: 29739902 [TBL] [Abstract][Full Text] [Related]
3. The effects of heat shock protein 90 inhibitors on apoptosis and viral replication in primary effusion lymphoma cells. Higashi C; Saji C; Yamada K; Kagawa H; Ohga R; Taira T; Fujimuro M Biol Pharm Bull; 2012; 35(5):725-30. PubMed ID: 22687408 [TBL] [Abstract][Full Text] [Related]
4. Proteasome inhibitors induce apoptosis and reduce viral replication in primary effusion lymphoma cells. Saji C; Higashi C; Niinaka Y; Yamada K; Noguchi K; Fujimuro M Biochem Biophys Res Commun; 2011 Dec; 415(4):573-8. PubMed ID: 22074820 [TBL] [Abstract][Full Text] [Related]
5. Triptolide decreases expression of latency-associated nuclear antigen 1 and reduces viral titers in Kaposi's sarcoma-associated and herpesvirus-related primary effusion lymphoma cells. Long C; Guo W; Zhou H; Wang J; Wang H; Sun X Int J Oncol; 2016 Apr; 48(4):1519-30. PubMed ID: 26821279 [TBL] [Abstract][Full Text] [Related]
6. Oncolytic Reactivation of KSHV as a Therapeutic Approach for Primary Effusion Lymphoma. Zhou F; Shimoda M; Olney L; Lyu Y; Tran K; Jiang G; Nakano K; Davis RR; Tepper CG; Maverakis E; Campbell M; Li Y; Dandekar S; Izumiya Y Mol Cancer Ther; 2017 Nov; 16(11):2627-2638. PubMed ID: 28847988 [TBL] [Abstract][Full Text] [Related]
7. Nm23-H1 induces apoptosis in primary effusion lymphoma cells via inhibition of NF-κB signaling through interaction with oncogenic latent protein vFLIP K13 of Kaposi's sarcoma-associated herpes virus. Mohanty S; Kumar A; Das P; Sahu SK; Mukherjee R; Ramachandranpillai R; Nair SS; Choudhuri T Cell Oncol (Dordr); 2022 Oct; 45(5):967-989. PubMed ID: 35964258 [TBL] [Abstract][Full Text] [Related]
8. Expression and Subcellular Localization of the Kaposi's Sarcoma-Associated Herpesvirus K15P Protein during Latency and Lytic Reactivation in Primary Effusion Lymphoma Cells. Smith CG; Kharkwal H; Wilson DW J Virol; 2017 Nov; 91(21):. PubMed ID: 28835496 [TBL] [Abstract][Full Text] [Related]
9. Cyclooxygenase-2-prostaglandin E2-eicosanoid receptor inflammatory axis: a key player in Kaposi's sarcoma-associated herpes virus associated malignancies. Paul AG; Chandran B; Sharma-Walia N Transl Res; 2013 Aug; 162(2):77-92. PubMed ID: 23567332 [TBL] [Abstract][Full Text] [Related]
10. Quercetin induces apoptosis and autophagy in primary effusion lymphoma cells by inhibiting PI3K/AKT/mTOR and STAT3 signaling pathways. Granato M; Rizzello C; Gilardini Montani MS; Cuomo L; Vitillo M; Santarelli R; Gonnella R; D'Orazi G; Faggioni A; Cirone M J Nutr Biochem; 2017 Mar; 41():124-136. PubMed ID: 28092744 [TBL] [Abstract][Full Text] [Related]
11. HIV-1 Vpr Inhibits Kaposi's Sarcoma-Associated Herpesvirus Lytic Replication by Inducing MicroRNA miR-942-5p and Activating NF-κB Signaling. Yan Q; Shen C; Qin J; Li W; Hu M; Lu H; Qin D; Zhu J; Gao SJ; Lu C J Virol; 2016 Oct; 90(19):8739-53. PubMed ID: 27440900 [TBL] [Abstract][Full Text] [Related]
12. LKB1 suppresses KSHV reactivation and promotes primary effusion lymphoma progression. Li G; Li Y; Tang X; Wang L; Yue S; He S; Li T J Virol; 2024 Sep; 98(9):e0060424. PubMed ID: 39194241 [TBL] [Abstract][Full Text] [Related]
14. Upregulation of MicroRNA 711 Mediates HIV-1 Vpr Promotion of Kaposi's Sarcoma-Associated Herpesvirus Latency and Induction of Pro-proliferation and Pro-survival Cytokines by Targeting the Notch/NF-κB-Signaling Axis. Yan Q; Zhao R; Shen C; Wang F; Li W; Gao SJ; Lu C J Virol; 2018 Sep; 92(18):. PubMed ID: 29976660 [TBL] [Abstract][Full Text] [Related]
15. Kaposi's Sarcoma-Associated Herpesvirus Latency Locus Renders B Cells Hyperresponsive to Secondary Infections. Sin SH; Eason AB; Bigi R; Kim Y; Kang S; Tan K; Seltzer TA; Venkataramanan R; An H; Dittmer DP J Virol; 2018 Oct; 92(19):. PubMed ID: 30021906 [TBL] [Abstract][Full Text] [Related]
16. Activated Nrf2 Interacts with Kaposi's Sarcoma-Associated Herpesvirus Latency Protein LANA-1 and Host Protein KAP1 To Mediate Global Lytic Gene Repression. Gjyshi O; Roy A; Dutta S; Veettil MV; Dutta D; Chandran B J Virol; 2015 Aug; 89(15):7874-92. PubMed ID: 25995248 [TBL] [Abstract][Full Text] [Related]
17. Diallyl trisulfide induces apoptosis by suppressing NF-κB signaling through destabilization of TRAF6 in primary effusion lymphoma. Shigemi Z; Furukawa Y; Hosokawa K; Minami S; Matsuhiro J; Nakata S; Watanabe T; Kagawa H; Nakagawa K; Takeda H; Fujimuro M Int J Oncol; 2016 Jan; 48(1):293-304. PubMed ID: 26647777 [TBL] [Abstract][Full Text] [Related]